186 related articles for article (PubMed ID: 22443173)
41. Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial.
Ahrén B; Masmiquel L; Kumar H; Sargin M; Karsbøl JD; Jacobsen SH; Chow F
Lancet Diabetes Endocrinol; 2017 May; 5(5):341-354. PubMed ID: 28385659
[TBL] [Abstract][Full Text] [Related]
42. Celecoxib for the prevention of colorectal adenomatous polyps.
Arber N; Eagle CJ; Spicak J; Rácz I; Dite P; Hajer J; Zavoral M; Lechuga MJ; Gerletti P; Tang J; Rosenstein RB; Macdonald K; Bhadra P; Fowler R; Wittes J; Zauber AG; Solomon SD; Levin B;
N Engl J Med; 2006 Aug; 355(9):885-95. PubMed ID: 16943401
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of differential effects of metformin treatment in obese children according to pubertal stage and genetic variations: study protocol for a randomized controlled trial.
Pastor-Villaescusa B; Caballero-Villarraso J; Cañete MD; Hoyos R; Maldonado J; Bueno G; Leis R; Gil Á; Cañete R; Aguilera CM
Trials; 2016 Jul; 17(1):323. PubMed ID: 27432166
[TBL] [Abstract][Full Text] [Related]
44. Investigation of the prevalence and number of aberrant crypt foci associated with human colorectal neoplasm.
Sakai E; Takahashi H; Kato S; Uchiyama T; Hosono K; Endo H; Maeda S; Yoneda M; Taguri M; Nakajima A
Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1918-24. PubMed ID: 21750169
[TBL] [Abstract][Full Text] [Related]
45. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
[TBL] [Abstract][Full Text] [Related]
46. Natural history of human aberrant crypt foci and correlation with risk factors for colorectal cancer.
Ohkubo H; Takahashi H; Yamada E; Sakai E; Higurashi T; Uchiyama T; Hosono K; Endo H; Taguri M; Nakajima A
Oncol Rep; 2012 May; 27(5):1475-80. PubMed ID: 22246586
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metformin.
Reusch J; Stewart MW; Perkins CM; Cirkel DT; Ye J; Perry CR; Reinhardt RR; Bode BW
Diabetes Obes Metab; 2014 Dec; 16(12):1257-64. PubMed ID: 25155146
[TBL] [Abstract][Full Text] [Related]
48. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi-center randomized controlled trial.
Feig DS; Murphy K; Asztalos E; Tomlinson G; Sanchez J; Zinman B; Ohlsson A; Ryan EA; Fantus IG; Armson AB; Lipscombe LL; Barrett JF;
BMC Pregnancy Childbirth; 2016 Jul; 16(1):173. PubMed ID: 27435163
[TBL] [Abstract][Full Text] [Related]
49. Efficacy and safety of three different endoscopic methods in treatment of 6-20 mm colorectal polyps.
Li D; Wang W; Xie J; Liu G; Wang R; Jiang C; Ye Z; Xu B; He X; Hong D
Scand J Gastroenterol; 2020 Mar; 55(3):362-370. PubMed ID: 32150478
[No Abstract] [Full Text] [Related]
50. [The role of epidemiologic research of the natural history of cancer for evaluating cancer screening programs--a prospective study of colorectal polyps on the occurrence of colorectal cancer].
Murakami R; Oshima A; Tsukuma H; Imanishi K; Otani T; Ishikawa H; Sato M; Fujimoto I
Gan No Rinsho; 1989 Jan; 35(2):188-94. PubMed ID: 2704127
[TBL] [Abstract][Full Text] [Related]
51. Metformin use is associated with a decreased incidence of colorectal adenomas in diabetic patients with previous colorectal cancer.
Lee JH; Jeon SM; Hong SP; Cheon JH; Kim TI; Kim WH
Dig Liver Dis; 2012 Dec; 44(12):1042-7. PubMed ID: 22789400
[TBL] [Abstract][Full Text] [Related]
52. Number of aberrant crypt foci in the rectum is a useful surrogate marker of colorectal adenoma recurrence.
Uchiyama T; Takahashi H; Endo H; Kato S; Sakai E; Hosono K; Yoneda M; Inamori M; Hippo Y; Nakagama H; Nakajima A
Dig Endosc; 2012 Sep; 24(5):353-7. PubMed ID: 22925289
[TBL] [Abstract][Full Text] [Related]
53. Possible protective role of metformin therapy on colonic polyps in acromegaly: an exploratory cross-sectional study.
Albertelli M; Nazzari E; Dotto A; Grasso LF; Sciallero S; Pirchio R; Rebora A; Boschetti M; Pivonello R; Ricci Bitti S; Colao AAL; Ferone D
Eur J Endocrinol; 2021 Mar; 184(3):419-425. PubMed ID: 33621192
[TBL] [Abstract][Full Text] [Related]
54. A randomized, placebo-controlled, preoperative trial of allopurinol in subjects with colorectal adenoma.
Puntoni M; Branchi D; Argusti A; Zanardi S; Crosta C; Meroni E; Munizzi F; Michetti P; Coccia G; De Roberto G; Bandelloni R; Turbino L; Minetti E; Mori M; Salvi S; Boccardo S; Gatteschi B; Benelli R; Sonzogni A; DeCensi A
Cancer Prev Res (Phila); 2013 Feb; 6(2):74-81. PubMed ID: 23213070
[TBL] [Abstract][Full Text] [Related]
55. Association of Sulindac and Erlotinib vs Placebo With Colorectal Neoplasia in Familial Adenomatous Polyposis: Secondary Analysis of a Randomized Clinical Trial.
Samadder NJ; Kuwada SK; Boucher KM; Byrne K; Kanth P; Samowitz W; Jones D; Tavtigian SV; Westover M; Berry T; Jasperson K; Pappas L; Smith L; Sample D; Burt RW; Neklason DW
JAMA Oncol; 2018 May; 4(5):671-677. PubMed ID: 29423501
[TBL] [Abstract][Full Text] [Related]
56. Growth of colorectal polyps: design of a prospective, randomized, placebo-controlled intervention study in patients with colorectal polyps.
Hofstad B; Vatn M; Hoff G; Larsen S; Osnes M
Eur J Cancer Prev; 1992 Oct; 1(6):415-22. PubMed ID: 1463996
[TBL] [Abstract][Full Text] [Related]
57. TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial.
Yoshino T; Mizunuma N; Yamazaki K; Nishina T; Komatsu Y; Baba H; Tsuji A; Yamaguchi K; Muro K; Sugimoto N; Tsuji Y; Moriwaki T; Esaki T; Hamada C; Tanase T; Ohtsu A
Lancet Oncol; 2012 Oct; 13(10):993-1001. PubMed ID: 22951287
[TBL] [Abstract][Full Text] [Related]
58. Metformin intervention against ovarian toxicity during chemotherapy for early breast cancer: Study protocol for a randomized double-blind placebo-controlled trial.
Zhang J; Ma X; Li Y; Liu R; Li Y; Zhang P; Ren W; Cui P; Wang B; Zhang M; Jin Y; Li X; Wang S
Maturitas; 2020 Jul; 137():1-6. PubMed ID: 32498930
[TBL] [Abstract][Full Text] [Related]
59. Suppressive effect of aspirin on aberrant crypt foci in patients with colorectal cancer.
Shpitz B; Klein E; Buklan G; Neufeld D; Nissan A; Freund HR; Grankin M; Bernheim J
Gut; 2003 Nov; 52(11):1598-601. PubMed ID: 14570729
[TBL] [Abstract][Full Text] [Related]
60. A randomized trial of aspirin to prevent colorectal adenomas.
Baron JA; Cole BF; Sandler RS; Haile RW; Ahnen D; Bresalier R; McKeown-Eyssen G; Summers RW; Rothstein R; Burke CA; Snover DC; Church TR; Allen JI; Beach M; Beck GJ; Bond JH; Byers T; Greenberg ER; Mandel JS; Marcon N; Mott LA; Pearson L; Saibil F; van Stolk RU
N Engl J Med; 2003 Mar; 348(10):891-9. PubMed ID: 12621133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
